Items Tagged ‘neuroendocrine tumors’

March 1st, 2017

Xermelo-new option for controlling symptoms of Carcinoid Syndrome

By

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea. Carcinoid syndrome is a cluster of symptoms that occurs in patients with advanced neuroendocrine tumors (NET) and the related diarrhea results […]

View full entry

Tags: carcinoid syndrome, General, NET, neuroendocrine tumors, News, Other News Topics (not Types of Cancer), Xermelo


February 23rd, 2017

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors

By

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here. Although neuroendocrine tumors have historically been considered rare, […]

View full entry

Tags: General, neuroendocrine tumors, News, Other News Topics (not Types of Cancer)


August 10th, 2015

Afinitor® Promising in Neuroendocrine Tumors Originating in Gastrointestinal Tract or Lungs

By

The drug Afinitor® (everolimus) is currently be studied in a Phase III clinical trial for patients with nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract or lungs. The trial is ongoing, but findings so far are promising: patients treated with Afinitor plus best supportive care appear to live longer without cancer progression than patients […]

View full entry

Tags: afinitor, everolimus, Gastric Cancer, General Lung Cancer, Lung Cancer, mtor, NET, neuroendocrine tumors, News, Recurrent Gastric Cancer, Stages III-IV Gastric Cancer


May 26th, 2015

Somatuline® Depot

By

Class: Biological Therapy Generic Name: Lanreotide Trade Name: Somatuline® Depot For which conditions is this drug approved? Somatuline Depot is approved for: The long-term treatment of people with acromegaly, a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. Somatuline Depot can be used in these patients when surgery […]

View full entry

Tags: acromegaly, Biological Therapy, Drug Dictionary, neuroendocrine tumors, S, somatostatin